Aria Howorth Oram

London UK

Contact Me Today

Aria specialises in M&A and venture capital transactions and has experience advising on a broad range of transactions, including domestic and cross-border M&A, joint ventures, financing rounds and general corporate advisory work.

CV

Since 2021 Associate, Taylor Wessing

2019 – 2021 Associate, Allen & Overy

2017 - 2019 Trainee solicitor, Allen & Overy

Career

Since 2021 Associate, Taylor Wessing

2019 – 2021 Associate, Allen & Overy

2017 - 2019 Trainee solicitor, Allen & Overy

Education

2017 LPC, BPP University

2016 GDL, BPP University

2015 BA (Hons) English Literature, Durham University

Aria's news & insights

View Aria's insights

Click here to find out more

Corporate/M&A & capital markets

Advising RSM UK on its transatlantic partnership with RSM US and Canada

6 November 2025

by multiple authors

Corporate/M&A & capital markets

United Fintech acquisition of CBA

13 February 2025

by multiple authors

Click here to find out more

Aria Howorth Oram

Expertise

Services and Groups

CV

Career

Education

Aria's news & insights

Advising RSM UK on its transatlantic partnership with RSM US and Canada

Aria Howorth Oram

Expertise

Services and Groups

CV

Career

Education

Aria's news & insights

Advising RSM UK on its transatlantic partnership with RSM US and Canada

Related news & insights

#7: State of the EU Crypto Industry: MiCA, Tokenisation and What Comes Next

Advising Eurofins on the sale of its electrical and electronic testing business for EUR575 million

Advising on Sona's US$45 million Series B funding

Taylor Wessing strengthens Corporate/M&A practice with Equity Partner Jan Hückel

Carbon Border Adjustment Mechanism (CBAM): From Reporting to Real Financial Impact

Sustainability Stories: Notpla

EU Inc. – The 28th Regime: How the European Commission intends to revolutionise the formation of companies

Investing in the German Audit and Tax Advisory Market – Opportunity Amid Regulatory Debate

More Than Share and Asset Deals: Innovative Transaction Structures for MedTech Companies

Advising on Tropic Biosciences' US$105 million Series C financing

Related people

Meet me at